nodes	percent_of_prediction	percent_of_DWPC	metapath
Desipramine—SLC22A1—hematologic cancer	0.169	0.775	CbGaD
Desipramine—ABCB1—hematologic cancer	0.0493	0.225	CbGaD
Desipramine—SLC22A3—Melphalan—hematologic cancer	0.0365	0.0737	CbGbCtD
Desipramine—CYP2C18—Ifosfamide—hematologic cancer	0.0201	0.0406	CbGbCtD
Desipramine—SLC22A2—Daunorubicin—hematologic cancer	0.0153	0.0309	CbGbCtD
Desipramine—ORM1—Imatinib—hematologic cancer	0.0142	0.0286	CbGbCtD
Desipramine—SLC22A2—Cytarabine—hematologic cancer	0.0135	0.0272	CbGbCtD
Desipramine—CYP2A6—Methoxsalen—hematologic cancer	0.0134	0.0271	CbGbCtD
Desipramine—SLC22A2—Cladribine—hematologic cancer	0.0127	0.0257	CbGbCtD
Desipramine—SLC22A3—Irinotecan—hematologic cancer	0.0124	0.0249	CbGbCtD
Desipramine—SLC22A1—Cytarabine—hematologic cancer	0.0117	0.0236	CbGbCtD
Desipramine—SLC22A2—Imatinib—hematologic cancer	0.0117	0.0236	CbGbCtD
Desipramine—CYP1A2—Anagrelide—hematologic cancer	0.0115	0.0231	CbGbCtD
Desipramine—CYP2B6—Thiotepa—hematologic cancer	0.0112	0.0226	CbGbCtD
Desipramine—SLC22A1—Cladribine—hematologic cancer	0.0111	0.0223	CbGbCtD
Desipramine—SLC22A3—Vincristine—hematologic cancer	0.0108	0.0218	CbGbCtD
Desipramine—SLC22A1—Imatinib—hematologic cancer	0.0102	0.0205	CbGbCtD
Desipramine—CYP2A6—Ifosfamide—hematologic cancer	0.00978	0.0197	CbGbCtD
Desipramine—CYP2E1—Thalidomide—hematologic cancer	0.00733	0.0148	CbGbCtD
Desipramine—ABCB1—Lenalidomide—hematologic cancer	0.00694	0.014	CbGbCtD
Desipramine—CYP2A6—Prednisolone—hematologic cancer	0.00652	0.0132	CbGbCtD
Desipramine—SLC22A2—Vinblastine—hematologic cancer	0.00651	0.0131	CbGbCtD
Desipramine—CYP2B6—Ifosfamide—hematologic cancer	0.00637	0.0128	CbGbCtD
Desipramine—CYP2E1—Dacarbazine—hematologic cancer	0.0063	0.0127	CbGbCtD
Desipramine—CYP2D6—Lomustine—hematologic cancer	0.00608	0.0123	CbGbCtD
Desipramine—CYP1A2—Carmustine—hematologic cancer	0.00602	0.0121	CbGbCtD
Desipramine—SLC22A2—Cisplatin—hematologic cancer	0.00597	0.012	CbGbCtD
Desipramine—CYP2B6—Nilotinib—hematologic cancer	0.00553	0.0112	CbGbCtD
Desipramine—CYP2D6—Idarubicin—hematologic cancer	0.00542	0.0109	CbGbCtD
Desipramine—CYP2C19—Bortezomib—hematologic cancer	0.00527	0.0106	CbGbCtD
Desipramine—CYP1A2—Methoxsalen—hematologic cancer	0.00512	0.0103	CbGbCtD
Desipramine—CYP2E1—Mitoxantrone—hematologic cancer	0.00489	0.00987	CbGbCtD
Desipramine—CYP1A2—Bortezomib—hematologic cancer	0.00487	0.00982	CbGbCtD
Desipramine—CYP1A2—Daunorubicin—hematologic cancer	0.00466	0.00939	CbGbCtD
Desipramine—CYP2D6—Hydroxyurea—hematologic cancer	0.00461	0.0093	CbGbCtD
Desipramine—CYP2C19—Thalidomide—hematologic cancer	0.0046	0.00927	CbGbCtD
Desipramine—CYP1A2—Alitretinoin—hematologic cancer	0.00456	0.0092	CbGbCtD
Desipramine—CYP2C19—Teniposide—hematologic cancer	0.00438	0.00884	CbGbCtD
Desipramine—CYP1A2—Thalidomide—hematologic cancer	0.00424	0.00855	CbGbCtD
Desipramine—CYP3A4—Bexarotene—hematologic cancer	0.00416	0.00839	CbGbCtD
Desipramine—ABCB1—Daunorubicin—hematologic cancer	0.00407	0.00821	CbGbCtD
Desipramine—CYP2C19—Ifosfamide—hematologic cancer	0.00405	0.00816	CbGbCtD
Desipramine—CYP2D6—Bortezomib—hematologic cancer	0.00401	0.00809	CbGbCtD
Desipramine—ABCB1—Alitretinoin—hematologic cancer	0.00399	0.00805	CbGbCtD
Desipramine—CYP3A4—Busulfan—hematologic cancer	0.00387	0.0078	CbGbCtD
Desipramine—CYP3A4—Lomustine—hematologic cancer	0.00387	0.0078	CbGbCtD
Desipramine—CYP2C19—Imatinib—hematologic cancer	0.00386	0.0078	CbGbCtD
Desipramine—CYP2A6—Dexamethasone—hematologic cancer	0.00384	0.00775	CbGbCtD
Desipramine—CYP2B6—Irinotecan—hematologic cancer	0.0038	0.00766	CbGbCtD
Desipramine—CYP1A2—Dacarbazine—hematologic cancer	0.00365	0.00736	CbGbCtD
Desipramine—CYP1A2—Imatinib—hematologic cancer	0.00357	0.00719	CbGbCtD
Desipramine—CYP3A4—Thiotepa—hematologic cancer	0.00345	0.00696	CbGbCtD
Desipramine—ABCB1—Imatinib—hematologic cancer	0.00312	0.00629	CbGbCtD
Desipramine—CYP2B6—Cisplatin—hematologic cancer	0.0031	0.00625	CbGbCtD
Desipramine—CYP2E1—Etoposide—hematologic cancer	0.00308	0.00622	CbGbCtD
Desipramine—CYP2D6—Imatinib—hematologic cancer	0.00294	0.00593	CbGbCtD
Desipramine—CYP1A2—Dasatinib—hematologic cancer	0.00286	0.00578	CbGbCtD
Desipramine—ABCB1—Nilotinib—hematologic cancer	0.00283	0.00572	CbGbCtD
Desipramine—ABCB1—Vinorelbine—hematologic cancer	0.00281	0.00567	CbGbCtD
Desipramine—CYP3A4—Methoxsalen—hematologic cancer	0.00268	0.00541	CbGbCtD
Desipramine—CYP2D6—Nilotinib—hematologic cancer	0.00267	0.00539	CbGbCtD
Desipramine—CYP2D6—Vinorelbine—hematologic cancer	0.00265	0.00534	CbGbCtD
Desipramine—CYP3A4—Bortezomib—hematologic cancer	0.00255	0.00514	CbGbCtD
Desipramine—CYP2C19—Prednisone—hematologic cancer	0.00255	0.00514	CbGbCtD
Desipramine—CYP2E1—Dexamethasone—hematologic cancer	0.00254	0.00512	CbGbCtD
Desipramine—ABCB1—Dasatinib—hematologic cancer	0.0025	0.00505	CbGbCtD
Desipramine—CYP2B6—Dexamethasone—hematologic cancer	0.0025	0.00505	CbGbCtD
Desipramine—ABCB1—Mitoxantrone—hematologic cancer	0.00247	0.00499	CbGbCtD
Desipramine—CYP3A4—Daunorubicin—hematologic cancer	0.00244	0.00492	CbGbCtD
Desipramine—ABCB1—Betamethasone—hematologic cancer	0.0022	0.00445	CbGbCtD
Desipramine—ABCB1—Gemcitabine—hematologic cancer	0.00219	0.00441	CbGbCtD
Desipramine—ABCB1—Prednisolone—hematologic cancer	0.00218	0.00439	CbGbCtD
Desipramine—CYP3A4—Cytarabine—hematologic cancer	0.00215	0.00434	CbGbCtD
Desipramine—CYP3A4—Teniposide—hematologic cancer	0.00212	0.00428	CbGbCtD
Desipramine—CYP2B6—Doxorubicin—hematologic cancer	0.00208	0.00419	CbGbCtD
Desipramine—ABCB1—Prednisone—hematologic cancer	0.00205	0.00415	CbGbCtD
Desipramine—CYP3A4—Ifosfamide—hematologic cancer	0.00196	0.00395	CbGbCtD
Desipramine—ABCB1—Irinotecan—hematologic cancer	0.00195	0.00393	CbGbCtD
Desipramine—CYP3A4—Imatinib—hematologic cancer	0.00187	0.00377	CbGbCtD
Desipramine—CYP1A2—Etoposide—hematologic cancer	0.00178	0.0036	CbGbCtD
Desipramine—CYP3A4—Ruxolitinib—hematologic cancer	0.00176	0.00355	CbGbCtD
Desipramine—ABCB1—Vinblastine—hematologic cancer	0.00173	0.00349	CbGbCtD
Desipramine—ABCB1—Vincristine—hematologic cancer	0.0017	0.00343	CbGbCtD
Desipramine—CYP3A4—Nilotinib—hematologic cancer	0.0017	0.00343	CbGbCtD
Desipramine—CYP3A4—Vinorelbine—hematologic cancer	0.00168	0.0034	CbGbCtD
Desipramine—CYP2D6—Vinblastine—hematologic cancer	0.00163	0.00329	CbGbCtD
Desipramine—CYP2C19—Dexamethasone—hematologic cancer	0.00159	0.00321	CbGbCtD
Desipramine—ABCB1—Cisplatin—hematologic cancer	0.00159	0.0032	CbGbCtD
Desipramine—ABCB1—Etoposide—hematologic cancer	0.00156	0.00315	CbGbCtD
Desipramine—CYP3A4—Triamcinolone—hematologic cancer	0.00154	0.00311	CbGbCtD
Desipramine—CYP3A4—Dasatinib—hematologic cancer	0.0015	0.00303	CbGbCtD
Desipramine—SMPD1—hematopoietic system—hematologic cancer	0.00148	0.0506	CbGeAlD
Desipramine—CYP3A4—Mitoxantrone—hematologic cancer	0.00148	0.00299	CbGbCtD
Desipramine—CYP3A4—Betamethasone—hematologic cancer	0.00132	0.00267	CbGbCtD
Desipramine—CYP3A4—Prednisolone—hematologic cancer	0.0013	0.00263	CbGbCtD
Desipramine—ABCB1—Dexamethasone—hematologic cancer	0.00128	0.00259	CbGbCtD
Desipramine—CYP3A4—Prednisone—hematologic cancer	0.00123	0.00248	CbGbCtD
Desipramine—CYP2D6—Dexamethasone—hematologic cancer	0.00121	0.00244	CbGbCtD
Desipramine—CYP3A4—Irinotecan—hematologic cancer	0.00117	0.00235	CbGbCtD
Desipramine—SMPD1—gonad—hematologic cancer	0.00113	0.0385	CbGeAlD
Desipramine—ABCB1—Doxorubicin—hematologic cancer	0.00106	0.00215	CbGbCtD
Desipramine—CYP3A4—Vinblastine—hematologic cancer	0.00104	0.00209	CbGbCtD
Desipramine—ABCB1—Methotrexate—hematologic cancer	0.00103	0.00208	CbGbCtD
Desipramine—CYP3A4—Vincristine—hematologic cancer	0.00102	0.00206	CbGbCtD
Desipramine—CYP2D6—Doxorubicin—hematologic cancer	0.001	0.00202	CbGbCtD
Desipramine—SMPD1—blood—hematologic cancer	0.000984	0.0335	CbGeAlD
Desipramine—CYP3A4—Etoposide—hematologic cancer	0.000935	0.00189	CbGbCtD
Desipramine—SMPD1—lung—hematologic cancer	0.000862	0.0294	CbGeAlD
Desipramine—SMPD1—testis—hematologic cancer	0.000814	0.0277	CbGeAlD
Desipramine—CYP3A4—Dexamethasone—hematologic cancer	0.000768	0.00155	CbGbCtD
Desipramine—ORM1—hematopoietic system—hematologic cancer	0.000727	0.0248	CbGeAlD
Desipramine—CHRM4—testis—hematologic cancer	0.000693	0.0236	CbGeAlD
Desipramine—SLC6A3—hematopoietic system—hematologic cancer	0.000676	0.023	CbGeAlD
Desipramine—CYP3A4—Doxorubicin—hematologic cancer	0.000638	0.00129	CbGbCtD
Desipramine—SLC22A3—hematopoietic system—hematologic cancer	0.000637	0.0217	CbGeAlD
Desipramine—SLC6A4—hematopoietic system—hematologic cancer	0.00062	0.0211	CbGeAlD
Desipramine—SMPD1—lymph node—hematologic cancer	0.00059	0.0201	CbGeAlD
Desipramine—HTR1A—hematopoietic system—hematologic cancer	0.00055	0.0187	CbGeAlD
Desipramine—CYP2C19—hematopoietic system—hematologic cancer	0.000513	0.0175	CbGeAlD
Desipramine—SLC22A3—gonad—hematologic cancer	0.000484	0.0165	CbGeAlD
Desipramine—ORM1—blood—hematologic cancer	0.000482	0.0164	CbGeAlD
Desipramine—ORM1—bone marrow—hematologic cancer	0.000466	0.0159	CbGeAlD
Desipramine—CYP2A6—lung—hematologic cancer	0.000464	0.0158	CbGeAlD
Desipramine—SLC22A4—blood—hematologic cancer	0.000463	0.0158	CbGeAlD
Desipramine—SLC22A4—bone marrow—hematologic cancer	0.000448	0.0153	CbGeAlD
Desipramine—SLC22A1—blood—hematologic cancer	0.000441	0.015	CbGeAlD
Desipramine—ORM1—lung—hematologic cancer	0.000422	0.0144	CbGeAlD
Desipramine—CYP1A2—hematopoietic system—hematologic cancer	0.000419	0.0143	CbGeAlD
Desipramine—SLC6A2—gonad—hematologic cancer	0.000415	0.0141	CbGeAlD
Desipramine—SLC6A4—blood—hematologic cancer	0.000411	0.014	CbGeAlD
Desipramine—SLC22A4—lung—hematologic cancer	0.000406	0.0138	CbGeAlD
Desipramine—CYP2B6—hematopoietic system—hematologic cancer	0.000402	0.0137	CbGeAlD
Desipramine—SLC6A3—lung—hematologic cancer	0.000393	0.0134	CbGeAlD
Desipramine—HRH1—hematopoietic system—hematologic cancer	0.000393	0.0134	CbGeAlD
Desipramine—CYP2E1—hematopoietic system—hematologic cancer	0.000377	0.0129	CbGeAlD
Desipramine—ADRB1—lung—hematologic cancer	0.000373	0.0127	CbGeAlD
Desipramine—SLC6A3—testis—hematologic cancer	0.000371	0.0126	CbGeAlD
Desipramine—SLC22A3—lung—hematologic cancer	0.00037	0.0126	CbGeAlD
Desipramine—SLC6A4—lung—hematologic cancer	0.00036	0.0123	CbGeAlD
Desipramine—CHRM1—lung—hematologic cancer	0.000359	0.0122	CbGeAlD
Desipramine—SLC22A3—testis—hematologic cancer	0.000349	0.0119	CbGeAlD
Desipramine—CYP2C19—blood—hematologic cancer	0.00034	0.0116	CbGeAlD
Desipramine—HTR2A—hematopoietic system—hematologic cancer	0.000328	0.0112	CbGeAlD
Desipramine—SLC6A2—lung—hematologic cancer	0.000317	0.0108	CbGeAlD
Desipramine—SLC22A5—blood—hematologic cancer	0.000307	0.0104	CbGeAlD
Desipramine—CYP2B6—gonad—hematologic cancer	0.000306	0.0104	CbGeAlD
Desipramine—CYP3A4—hematopoietic system—hematologic cancer	0.000304	0.0103	CbGeAlD
Desipramine—CHRM3—testis—hematologic cancer	0.000303	0.0103	CbGeAlD
Desipramine—SLC6A2—testis—hematologic cancer	0.000299	0.0102	CbGeAlD
Desipramine—CYP2D6—hematopoietic system—hematologic cancer	0.000299	0.0102	CbGeAlD
Desipramine—ORM1—lymph node—hematologic cancer	0.000289	0.00984	CbGeAlD
Desipramine—DRD2—lung—hematologic cancer	0.000289	0.00984	CbGeAlD
Desipramine—SLC22A4—lymph node—hematologic cancer	0.000278	0.00947	CbGeAlD
Desipramine—CYP1A2—blood—hematologic cancer	0.000278	0.00947	CbGeAlD
Desipramine—DRD2—testis—hematologic cancer	0.000272	0.00928	CbGeAlD
Desipramine—SLC22A5—lung—hematologic cancer	0.000269	0.00916	CbGeAlD
Desipramine—CYP2B6—blood—hematologic cancer	0.000266	0.00907	CbGeAlD
Desipramine—SLC22A5—testis—hematologic cancer	0.000254	0.00864	CbGeAlD
Desipramine—SLC22A3—lymph node—hematologic cancer	0.000253	0.00862	CbGeAlD
Desipramine—CYP2E1—blood—hematologic cancer	0.00025	0.00852	CbGeAlD
Desipramine—HTR2A—gonad—hematologic cancer	0.000249	0.00849	CbGeAlD
Desipramine—CYP1A2—lung—hematologic cancer	0.000244	0.0083	CbGeAlD
Desipramine—CYP2B6—lung—hematologic cancer	0.000233	0.00795	CbGeAlD
Desipramine—HRH1—lung—hematologic cancer	0.000228	0.00777	CbGeAlD
Desipramine—Benazepril—MTHFR—hematologic cancer	0.000226	0.174	CrCbGaD
Desipramine—CYP2B6—testis—hematologic cancer	0.00022	0.00751	CbGeAlD
Desipramine—CYP2E1—lung—hematologic cancer	0.000219	0.00746	CbGeAlD
Desipramine—HTR2A—blood—hematologic cancer	0.000217	0.0074	CbGeAlD
Desipramine—SLC6A2—lymph node—hematologic cancer	0.000217	0.00738	CbGeAlD
Desipramine—HRH1—testis—hematologic cancer	0.000215	0.00733	CbGeAlD
Desipramine—ABCB1—hematopoietic system—hematologic cancer	0.000215	0.00732	CbGeAlD
Desipramine—CYP2E1—testis—hematologic cancer	0.000207	0.00704	CbGeAlD
Desipramine—CYP3A4—blood—hematologic cancer	0.000201	0.00685	CbGeAlD
Desipramine—CYP2D6—blood—hematologic cancer	0.000198	0.00674	CbGeAlD
Desipramine—HTR2A—lung—hematologic cancer	0.00019	0.00649	CbGeAlD
Desipramine—SLC22A5—lymph node—hematologic cancer	0.000184	0.00626	CbGeAlD
Desipramine—HTR2A—testis—hematologic cancer	0.00018	0.00612	CbGeAlD
Desipramine—CYP2D6—testis—hematologic cancer	0.000164	0.00558	CbGeAlD
Desipramine—ABCB1—gonad—hematologic cancer	0.000163	0.00557	CbGeAlD
Desipramine—HRH1—lymph node—hematologic cancer	0.000156	0.00531	CbGeAlD
Desipramine—Acepromazine—SLC22A1—hematologic cancer	0.000142	0.11	CrCbGaD
Desipramine—ABCB1—blood—hematologic cancer	0.000142	0.00485	CbGeAlD
Desipramine—ABCB1—bone marrow—hematologic cancer	0.000138	0.00469	CbGeAlD
Desipramine—ABCB1—lung—hematologic cancer	0.000125	0.00425	CbGeAlD
Desipramine—ABCB1—testis—hematologic cancer	0.000118	0.00401	CbGeAlD
Desipramine—Clomipramine—GSTP1—hematologic cancer	0.000117	0.0902	CrCbGaD
Desipramine—ABCB1—lymph node—hematologic cancer	8.54e-05	0.00291	CbGeAlD
Desipramine—Protriptyline—ABCB1—hematologic cancer	8.03e-05	0.0618	CrCbGaD
Desipramine—Chlorpromazine—SLC22A1—hematologic cancer	7.43e-05	0.0572	CrCbGaD
Desipramine—Imipramine—SLC22A1—hematologic cancer	7.39e-05	0.0569	CrCbGaD
Desipramine—Epinastine—ABCB1—hematologic cancer	5.95e-05	0.0458	CrCbGaD
Desipramine—Oxcarbazepine—ALB—hematologic cancer	5.75e-05	0.0442	CrCbGaD
Desipramine—Maprotiline—ABCB1—hematologic cancer	5.12e-05	0.0394	CrCbGaD
Desipramine—Triflupromazine—ABCB1—hematologic cancer	4.48e-05	0.0345	CrCbGaD
Desipramine—Acepromazine—ALB—hematologic cancer	4.34e-05	0.0334	CrCbGaD
Desipramine—Carbamazepine—ABCB1—hematologic cancer	3.74e-05	0.0288	CrCbGaD
Desipramine—Clomipramine—ALB—hematologic cancer	3.3e-05	0.0254	CrCbGaD
Desipramine—Rash—Ifosfamide—hematologic cancer	3.27e-05	0.000203	CcSEcCtD
Desipramine—Dermatitis—Ifosfamide—hematologic cancer	3.27e-05	0.000203	CcSEcCtD
Desipramine—Neuropathy peripheral—Doxorubicin—hematologic cancer	3.27e-05	0.000203	CcSEcCtD
Desipramine—Dizziness—Irinotecan—hematologic cancer	3.26e-05	0.000202	CcSEcCtD
Desipramine—Urticaria—Etoposide—hematologic cancer	3.26e-05	0.000202	CcSEcCtD
Desipramine—Stomatitis—Doxorubicin—hematologic cancer	3.25e-05	0.000202	CcSEcCtD
Desipramine—Jaundice—Doxorubicin—hematologic cancer	3.25e-05	0.000202	CcSEcCtD
Desipramine—Malaise—Prednisone—hematologic cancer	3.25e-05	0.000201	CcSEcCtD
Desipramine—Abdominal pain—Etoposide—hematologic cancer	3.24e-05	0.000201	CcSEcCtD
Desipramine—Body temperature increased—Etoposide—hematologic cancer	3.24e-05	0.000201	CcSEcCtD
Desipramine—Hepatitis—Epirubicin—hematologic cancer	3.24e-05	0.000201	CcSEcCtD
Desipramine—Nortriptyline—ALB—hematologic cancer	3.22e-05	0.0248	CrCbGaD
Desipramine—Tinnitus—Methotrexate—hematologic cancer	3.22e-05	0.0002	CcSEcCtD
Desipramine—Hypoaesthesia—Epirubicin—hematologic cancer	3.22e-05	0.0002	CcSEcCtD
Desipramine—Vomiting—Vincristine—hematologic cancer	3.22e-05	0.0002	CcSEcCtD
Desipramine—Anorexia—Dexamethasone—hematologic cancer	3.22e-05	0.0002	CcSEcCtD
Desipramine—Anorexia—Betamethasone—hematologic cancer	3.22e-05	0.0002	CcSEcCtD
Desipramine—Urticaria—Prednisolone—hematologic cancer	3.21e-05	0.000199	CcSEcCtD
Desipramine—Asthenia—Cisplatin—hematologic cancer	3.21e-05	0.000199	CcSEcCtD
Desipramine—Fatigue—Triamcinolone—hematologic cancer	3.21e-05	0.000199	CcSEcCtD
Desipramine—Rash—Vincristine—hematologic cancer	3.19e-05	0.000198	CcSEcCtD
Desipramine—Dermatitis—Vincristine—hematologic cancer	3.19e-05	0.000198	CcSEcCtD
Desipramine—Headache—Vincristine—hematologic cancer	3.17e-05	0.000197	CcSEcCtD
Desipramine—Hypotension—Dexamethasone—hematologic cancer	3.15e-05	0.000196	CcSEcCtD
Desipramine—Hypotension—Betamethasone—hematologic cancer	3.15e-05	0.000196	CcSEcCtD
Desipramine—Nausea—Carmustine—hematologic cancer	3.15e-05	0.000195	CcSEcCtD
Desipramine—Clomipramine—ABCB1—hematologic cancer	3.15e-05	0.0242	CrCbGaD
Desipramine—Vomiting—Mitoxantrone—hematologic cancer	3.14e-05	0.000194	CcSEcCtD
Desipramine—Vomiting—Irinotecan—hematologic cancer	3.14e-05	0.000194	CcSEcCtD
Desipramine—Nausea—Alitretinoin—hematologic cancer	3.12e-05	0.000194	CcSEcCtD
Desipramine—Convulsion—Prednisone—hematologic cancer	3.12e-05	0.000194	CcSEcCtD
Desipramine—Agranulocytosis—Doxorubicin—hematologic cancer	3.11e-05	0.000193	CcSEcCtD
Desipramine—Hypertension—Prednisone—hematologic cancer	3.11e-05	0.000193	CcSEcCtD
Desipramine—Rash—Irinotecan—hematologic cancer	3.11e-05	0.000193	CcSEcCtD
Desipramine—Rash—Mitoxantrone—hematologic cancer	3.11e-05	0.000193	CcSEcCtD
Desipramine—Dermatitis—Irinotecan—hematologic cancer	3.11e-05	0.000193	CcSEcCtD
Desipramine—Dermatitis—Mitoxantrone—hematologic cancer	3.11e-05	0.000193	CcSEcCtD
Desipramine—Headache—Irinotecan—hematologic cancer	3.09e-05	0.000192	CcSEcCtD
Desipramine—Headache—Mitoxantrone—hematologic cancer	3.09e-05	0.000192	CcSEcCtD
Desipramine—Nausea—Ifosfamide—hematologic cancer	3.09e-05	0.000191	CcSEcCtD
Desipramine—Feeling abnormal—Triamcinolone—hematologic cancer	3.07e-05	0.00019	CcSEcCtD
Desipramine—Diarrhoea—Cisplatin—hematologic cancer	3.06e-05	0.00019	CcSEcCtD
Desipramine—Anxiety—Prednisone—hematologic cancer	3.06e-05	0.00019	CcSEcCtD
Desipramine—Alopecia—Methotrexate—hematologic cancer	3.06e-05	0.000189	CcSEcCtD
Desipramine—Vomiting—Gemcitabine—hematologic cancer	3.05e-05	0.000189	CcSEcCtD
Desipramine—Insomnia—Betamethasone—hematologic cancer	3.05e-05	0.000189	CcSEcCtD
Desipramine—Insomnia—Dexamethasone—hematologic cancer	3.05e-05	0.000189	CcSEcCtD
Desipramine—Paraesthesia—Dexamethasone—hematologic cancer	3.03e-05	0.000188	CcSEcCtD
Desipramine—Paraesthesia—Betamethasone—hematologic cancer	3.03e-05	0.000188	CcSEcCtD
Desipramine—Discomfort—Prednisone—hematologic cancer	3.03e-05	0.000188	CcSEcCtD
Desipramine—Rash—Gemcitabine—hematologic cancer	3.03e-05	0.000188	CcSEcCtD
Desipramine—Dermatitis—Gemcitabine—hematologic cancer	3.03e-05	0.000188	CcSEcCtD
Desipramine—Tinnitus—Epirubicin—hematologic cancer	3.02e-05	0.000187	CcSEcCtD
Desipramine—Headache—Gemcitabine—hematologic cancer	3.01e-05	0.000187	CcSEcCtD
Desipramine—Nausea—Vincristine—hematologic cancer	3.01e-05	0.000187	CcSEcCtD
Desipramine—Flushing—Epirubicin—hematologic cancer	3e-05	0.000186	CcSEcCtD
Desipramine—Hepatitis—Doxorubicin—hematologic cancer	2.99e-05	0.000186	CcSEcCtD
Desipramine—Hypoaesthesia—Doxorubicin—hematologic cancer	2.98e-05	0.000185	CcSEcCtD
Desipramine—Dyspepsia—Betamethasone—hematologic cancer	2.97e-05	0.000184	CcSEcCtD
Desipramine—Dyspepsia—Dexamethasone—hematologic cancer	2.97e-05	0.000184	CcSEcCtD
Desipramine—Urticaria—Triamcinolone—hematologic cancer	2.96e-05	0.000183	CcSEcCtD
Desipramine—Dysgeusia—Methotrexate—hematologic cancer	2.95e-05	0.000183	CcSEcCtD
Desipramine—Asthenia—Etoposide—hematologic cancer	2.94e-05	0.000182	CcSEcCtD
Desipramine—Body temperature increased—Triamcinolone—hematologic cancer	2.94e-05	0.000182	CcSEcCtD
Desipramine—Oedema—Prednisone—hematologic cancer	2.94e-05	0.000182	CcSEcCtD
Desipramine—Decreased appetite—Dexamethasone—hematologic cancer	2.93e-05	0.000182	CcSEcCtD
Desipramine—Decreased appetite—Betamethasone—hematologic cancer	2.93e-05	0.000182	CcSEcCtD
Desipramine—Nausea—Mitoxantrone—hematologic cancer	2.93e-05	0.000182	CcSEcCtD
Desipramine—Nausea—Irinotecan—hematologic cancer	2.93e-05	0.000182	CcSEcCtD
Desipramine—Fatigue—Betamethasone—hematologic cancer	2.91e-05	0.00018	CcSEcCtD
Desipramine—Fatigue—Dexamethasone—hematologic cancer	2.91e-05	0.00018	CcSEcCtD
Desipramine—Pruritus—Etoposide—hematologic cancer	2.9e-05	0.00018	CcSEcCtD
Desipramine—Trimipramine—ABCB1—hematologic cancer	2.9e-05	0.0223	CrCbGaD
Desipramine—Arrhythmia—Epirubicin—hematologic cancer	2.89e-05	0.000179	CcSEcCtD
Desipramine—Tachycardia—Prednisone—hematologic cancer	2.87e-05	0.000178	CcSEcCtD
Desipramine—Alopecia—Epirubicin—hematologic cancer	2.86e-05	0.000177	CcSEcCtD
Desipramine—Nausea—Gemcitabine—hematologic cancer	2.85e-05	0.000177	CcSEcCtD
Desipramine—Vomiting—Cisplatin—hematologic cancer	2.85e-05	0.000177	CcSEcCtD
Desipramine—Vision blurred—Methotrexate—hematologic cancer	2.84e-05	0.000176	CcSEcCtD
Desipramine—Rash—Cisplatin—hematologic cancer	2.82e-05	0.000175	CcSEcCtD
Desipramine—Dermatitis—Cisplatin—hematologic cancer	2.82e-05	0.000175	CcSEcCtD
Desipramine—Diarrhoea—Etoposide—hematologic cancer	2.81e-05	0.000174	CcSEcCtD
Desipramine—Anorexia—Prednisone—hematologic cancer	2.8e-05	0.000174	CcSEcCtD
Desipramine—Ill-defined disorder—Methotrexate—hematologic cancer	2.79e-05	0.000173	CcSEcCtD
Desipramine—Tinnitus—Doxorubicin—hematologic cancer	2.79e-05	0.000173	CcSEcCtD
Desipramine—Promethazine—ABCB1—hematologic cancer	2.79e-05	0.0215	CrCbGaD
Desipramine—Feeling abnormal—Betamethasone—hematologic cancer	2.78e-05	0.000172	CcSEcCtD
Desipramine—Feeling abnormal—Dexamethasone—hematologic cancer	2.78e-05	0.000172	CcSEcCtD
Desipramine—Flushing—Doxorubicin—hematologic cancer	2.78e-05	0.000172	CcSEcCtD
Desipramine—Doxepin—ABCB1—hematologic cancer	2.76e-05	0.0213	CrCbGaD
Desipramine—Dysgeusia—Epirubicin—hematologic cancer	2.76e-05	0.000171	CcSEcCtD
Desipramine—Malaise—Methotrexate—hematologic cancer	2.72e-05	0.000168	CcSEcCtD
Desipramine—Dizziness—Etoposide—hematologic cancer	2.71e-05	0.000168	CcSEcCtD
Desipramine—Urticaria—Dexamethasone—hematologic cancer	2.68e-05	0.000166	CcSEcCtD
Desipramine—Urticaria—Betamethasone—hematologic cancer	2.68e-05	0.000166	CcSEcCtD
Desipramine—Dizziness—Prednisolone—hematologic cancer	2.68e-05	0.000166	CcSEcCtD
Desipramine—Arrhythmia—Doxorubicin—hematologic cancer	2.68e-05	0.000166	CcSEcCtD
Desipramine—Asthenia—Triamcinolone—hematologic cancer	2.67e-05	0.000166	CcSEcCtD
Desipramine—Body temperature increased—Dexamethasone—hematologic cancer	2.67e-05	0.000165	CcSEcCtD
Desipramine—Abdominal pain—Dexamethasone—hematologic cancer	2.67e-05	0.000165	CcSEcCtD
Desipramine—Body temperature increased—Betamethasone—hematologic cancer	2.67e-05	0.000165	CcSEcCtD
Desipramine—Abdominal pain—Betamethasone—hematologic cancer	2.67e-05	0.000165	CcSEcCtD
Desipramine—Nausea—Cisplatin—hematologic cancer	2.66e-05	0.000165	CcSEcCtD
Desipramine—Insomnia—Prednisone—hematologic cancer	2.66e-05	0.000165	CcSEcCtD
Desipramine—Vision blurred—Epirubicin—hematologic cancer	2.66e-05	0.000165	CcSEcCtD
Desipramine—Alopecia—Doxorubicin—hematologic cancer	2.65e-05	0.000164	CcSEcCtD
Desipramine—Paraesthesia—Prednisone—hematologic cancer	2.64e-05	0.000164	CcSEcCtD
Desipramine—Pruritus—Triamcinolone—hematologic cancer	2.63e-05	0.000163	CcSEcCtD
Desipramine—Ill-defined disorder—Epirubicin—hematologic cancer	2.61e-05	0.000162	CcSEcCtD
Desipramine—Convulsion—Methotrexate—hematologic cancer	2.61e-05	0.000162	CcSEcCtD
Desipramine—Vomiting—Etoposide—hematologic cancer	2.61e-05	0.000162	CcSEcCtD
Desipramine—Agitation—Epirubicin—hematologic cancer	2.59e-05	0.000161	CcSEcCtD
Desipramine—Dyspepsia—Prednisone—hematologic cancer	2.59e-05	0.00016	CcSEcCtD
Desipramine—Rash—Etoposide—hematologic cancer	2.59e-05	0.00016	CcSEcCtD
Desipramine—Dermatitis—Etoposide—hematologic cancer	2.58e-05	0.00016	CcSEcCtD
Desipramine—Headache—Etoposide—hematologic cancer	2.57e-05	0.000159	CcSEcCtD
Desipramine—Decreased appetite—Prednisone—hematologic cancer	2.56e-05	0.000158	CcSEcCtD
Desipramine—Dysgeusia—Doxorubicin—hematologic cancer	2.55e-05	0.000158	CcSEcCtD
Desipramine—Rash—Prednisolone—hematologic cancer	2.55e-05	0.000158	CcSEcCtD
Desipramine—Dermatitis—Prednisolone—hematologic cancer	2.55e-05	0.000158	CcSEcCtD
Desipramine—Malaise—Epirubicin—hematologic cancer	2.54e-05	0.000158	CcSEcCtD
Desipramine—Fatigue—Prednisone—hematologic cancer	2.53e-05	0.000157	CcSEcCtD
Desipramine—Headache—Prednisolone—hematologic cancer	2.53e-05	0.000157	CcSEcCtD
Desipramine—Discomfort—Methotrexate—hematologic cancer	2.53e-05	0.000157	CcSEcCtD
Desipramine—Constipation—Prednisone—hematologic cancer	2.51e-05	0.000156	CcSEcCtD
Desipramine—Palpitations—Epirubicin—hematologic cancer	2.49e-05	0.000154	CcSEcCtD
Desipramine—Confusional state—Methotrexate—hematologic cancer	2.48e-05	0.000154	CcSEcCtD
Desipramine—Dizziness—Triamcinolone—hematologic cancer	2.46e-05	0.000153	CcSEcCtD
Desipramine—Vision blurred—Doxorubicin—hematologic cancer	2.46e-05	0.000152	CcSEcCtD
Desipramine—Convulsion—Epirubicin—hematologic cancer	2.44e-05	0.000151	CcSEcCtD
Desipramine—Nausea—Etoposide—hematologic cancer	2.44e-05	0.000151	CcSEcCtD
Desipramine—Hypertension—Epirubicin—hematologic cancer	2.43e-05	0.000151	CcSEcCtD
Desipramine—Feeling abnormal—Prednisone—hematologic cancer	2.42e-05	0.00015	CcSEcCtD
Desipramine—Asthenia—Betamethasone—hematologic cancer	2.42e-05	0.00015	CcSEcCtD
Desipramine—Asthenia—Dexamethasone—hematologic cancer	2.42e-05	0.00015	CcSEcCtD
Desipramine—Ill-defined disorder—Doxorubicin—hematologic cancer	2.42e-05	0.00015	CcSEcCtD
Desipramine—Thrombocytopenia—Methotrexate—hematologic cancer	2.41e-05	0.000149	CcSEcCtD
Desipramine—Nausea—Prednisolone—hematologic cancer	2.4e-05	0.000149	CcSEcCtD
Desipramine—Agitation—Doxorubicin—hematologic cancer	2.4e-05	0.000149	CcSEcCtD
Desipramine—Anxiety—Epirubicin—hematologic cancer	2.39e-05	0.000148	CcSEcCtD
Desipramine—Pruritus—Betamethasone—hematologic cancer	2.39e-05	0.000148	CcSEcCtD
Desipramine—Pruritus—Dexamethasone—hematologic cancer	2.39e-05	0.000148	CcSEcCtD
Desipramine—Discomfort—Epirubicin—hematologic cancer	2.37e-05	0.000147	CcSEcCtD
Desipramine—Vomiting—Triamcinolone—hematologic cancer	2.37e-05	0.000147	CcSEcCtD
Desipramine—Malaise—Doxorubicin—hematologic cancer	2.35e-05	0.000146	CcSEcCtD
Desipramine—Rash—Triamcinolone—hematologic cancer	2.35e-05	0.000145	CcSEcCtD
Desipramine—Dry mouth—Epirubicin—hematologic cancer	2.35e-05	0.000145	CcSEcCtD
Desipramine—Dermatitis—Triamcinolone—hematologic cancer	2.34e-05	0.000145	CcSEcCtD
Desipramine—Anorexia—Methotrexate—hematologic cancer	2.34e-05	0.000145	CcSEcCtD
Desipramine—Urticaria—Prednisone—hematologic cancer	2.34e-05	0.000145	CcSEcCtD
Desipramine—Headache—Triamcinolone—hematologic cancer	2.33e-05	0.000145	CcSEcCtD
Desipramine—Abdominal pain—Prednisone—hematologic cancer	2.32e-05	0.000144	CcSEcCtD
Desipramine—Body temperature increased—Prednisone—hematologic cancer	2.32e-05	0.000144	CcSEcCtD
Desipramine—Confusional state—Epirubicin—hematologic cancer	2.32e-05	0.000144	CcSEcCtD
Desipramine—Diarrhoea—Betamethasone—hematologic cancer	2.31e-05	0.000143	CcSEcCtD
Desipramine—Diarrhoea—Dexamethasone—hematologic cancer	2.31e-05	0.000143	CcSEcCtD
Desipramine—Palpitations—Doxorubicin—hematologic cancer	2.3e-05	0.000143	CcSEcCtD
Desipramine—Oedema—Epirubicin—hematologic cancer	2.3e-05	0.000143	CcSEcCtD
Desipramine—Hypotension—Methotrexate—hematologic cancer	2.3e-05	0.000142	CcSEcCtD
Desipramine—Chlorpromazine—ALB—hematologic cancer	2.26e-05	0.0174	CrCbGaD
Desipramine—Convulsion—Doxorubicin—hematologic cancer	2.26e-05	0.00014	CcSEcCtD
Desipramine—Thrombocytopenia—Epirubicin—hematologic cancer	2.25e-05	0.00014	CcSEcCtD
Desipramine—Hypertension—Doxorubicin—hematologic cancer	2.25e-05	0.00014	CcSEcCtD
Desipramine—Tachycardia—Epirubicin—hematologic cancer	2.24e-05	0.000139	CcSEcCtD
Desipramine—Amitriptyline—ALB—hematologic cancer	2.24e-05	0.0172	CrCbGaD
Desipramine—Dizziness—Dexamethasone—hematologic cancer	2.23e-05	0.000138	CcSEcCtD
Desipramine—Dizziness—Betamethasone—hematologic cancer	2.23e-05	0.000138	CcSEcCtD
Desipramine—Insomnia—Methotrexate—hematologic cancer	2.22e-05	0.000138	CcSEcCtD
Desipramine—Anxiety—Doxorubicin—hematologic cancer	2.21e-05	0.000137	CcSEcCtD
Desipramine—Nausea—Triamcinolone—hematologic cancer	2.21e-05	0.000137	CcSEcCtD
Desipramine—Paraesthesia—Methotrexate—hematologic cancer	2.21e-05	0.000137	CcSEcCtD
Desipramine—Discomfort—Doxorubicin—hematologic cancer	2.19e-05	0.000136	CcSEcCtD
Desipramine—Anorexia—Epirubicin—hematologic cancer	2.19e-05	0.000136	CcSEcCtD
Desipramine—Somnolence—Methotrexate—hematologic cancer	2.18e-05	0.000135	CcSEcCtD
Desipramine—Dry mouth—Doxorubicin—hematologic cancer	2.17e-05	0.000135	CcSEcCtD
Desipramine—Dyspepsia—Methotrexate—hematologic cancer	2.16e-05	0.000134	CcSEcCtD
Desipramine—Chlorpromazine—ABCB1—hematologic cancer	2.16e-05	0.0166	CrCbGaD
Desipramine—Imipramine—ABCB1—hematologic cancer	2.15e-05	0.0165	CrCbGaD
Desipramine—Hypotension—Epirubicin—hematologic cancer	2.15e-05	0.000133	CcSEcCtD
Desipramine—Vomiting—Dexamethasone—hematologic cancer	2.15e-05	0.000133	CcSEcCtD
Desipramine—Vomiting—Betamethasone—hematologic cancer	2.15e-05	0.000133	CcSEcCtD
Desipramine—Confusional state—Doxorubicin—hematologic cancer	2.15e-05	0.000133	CcSEcCtD
Desipramine—Decreased appetite—Methotrexate—hematologic cancer	2.14e-05	0.000132	CcSEcCtD
Desipramine—Amitriptyline—ABCB1—hematologic cancer	2.14e-05	0.0164	CrCbGaD
Desipramine—Rash—Betamethasone—hematologic cancer	2.13e-05	0.000132	CcSEcCtD
Desipramine—Rash—Dexamethasone—hematologic cancer	2.13e-05	0.000132	CcSEcCtD
Desipramine—Oedema—Doxorubicin—hematologic cancer	2.13e-05	0.000132	CcSEcCtD
Desipramine—Dermatitis—Dexamethasone—hematologic cancer	2.13e-05	0.000132	CcSEcCtD
Desipramine—Dermatitis—Betamethasone—hematologic cancer	2.13e-05	0.000132	CcSEcCtD
Desipramine—Fatigue—Methotrexate—hematologic cancer	2.12e-05	0.000131	CcSEcCtD
Desipramine—Headache—Dexamethasone—hematologic cancer	2.12e-05	0.000131	CcSEcCtD
Desipramine—Headache—Betamethasone—hematologic cancer	2.12e-05	0.000131	CcSEcCtD
Desipramine—Asthenia—Prednisone—hematologic cancer	2.11e-05	0.000131	CcSEcCtD
Desipramine—Thrombocytopenia—Doxorubicin—hematologic cancer	2.08e-05	0.000129	CcSEcCtD
Desipramine—Pruritus—Prednisone—hematologic cancer	2.08e-05	0.000129	CcSEcCtD
Desipramine—Insomnia—Epirubicin—hematologic cancer	2.08e-05	0.000129	CcSEcCtD
Desipramine—Tachycardia—Doxorubicin—hematologic cancer	2.08e-05	0.000129	CcSEcCtD
Desipramine—Paraesthesia—Epirubicin—hematologic cancer	2.06e-05	0.000128	CcSEcCtD
Desipramine—Somnolence—Epirubicin—hematologic cancer	2.04e-05	0.000127	CcSEcCtD
Desipramine—Anorexia—Doxorubicin—hematologic cancer	2.03e-05	0.000126	CcSEcCtD
Desipramine—Feeling abnormal—Methotrexate—hematologic cancer	2.02e-05	0.000126	CcSEcCtD
Desipramine—Dyspepsia—Epirubicin—hematologic cancer	2.02e-05	0.000126	CcSEcCtD
Desipramine—Diarrhoea—Prednisone—hematologic cancer	2.01e-05	0.000125	CcSEcCtD
Desipramine—Nausea—Dexamethasone—hematologic cancer	2.01e-05	0.000124	CcSEcCtD
Desipramine—Nausea—Betamethasone—hematologic cancer	2.01e-05	0.000124	CcSEcCtD
Desipramine—Decreased appetite—Epirubicin—hematologic cancer	2e-05	0.000124	CcSEcCtD
Desipramine—Hypotension—Doxorubicin—hematologic cancer	1.99e-05	0.000123	CcSEcCtD
Desipramine—Fatigue—Epirubicin—hematologic cancer	1.98e-05	0.000123	CcSEcCtD
Desipramine—Constipation—Epirubicin—hematologic cancer	1.97e-05	0.000122	CcSEcCtD
Desipramine—Urticaria—Methotrexate—hematologic cancer	1.95e-05	0.000121	CcSEcCtD
Desipramine—Dizziness—Prednisone—hematologic cancer	1.94e-05	0.000121	CcSEcCtD
Desipramine—Body temperature increased—Methotrexate—hematologic cancer	1.94e-05	0.00012	CcSEcCtD
Desipramine—Abdominal pain—Methotrexate—hematologic cancer	1.94e-05	0.00012	CcSEcCtD
Desipramine—Insomnia—Doxorubicin—hematologic cancer	1.92e-05	0.000119	CcSEcCtD
Desipramine—Paraesthesia—Doxorubicin—hematologic cancer	1.91e-05	0.000118	CcSEcCtD
Desipramine—Feeling abnormal—Epirubicin—hematologic cancer	1.89e-05	0.000117	CcSEcCtD
Desipramine—Somnolence—Doxorubicin—hematologic cancer	1.89e-05	0.000117	CcSEcCtD
Desipramine—Dyspepsia—Doxorubicin—hematologic cancer	1.87e-05	0.000116	CcSEcCtD
Desipramine—Vomiting—Prednisone—hematologic cancer	1.87e-05	0.000116	CcSEcCtD
Desipramine—Rash—Prednisone—hematologic cancer	1.85e-05	0.000115	CcSEcCtD
Desipramine—Dermatitis—Prednisone—hematologic cancer	1.85e-05	0.000115	CcSEcCtD
Desipramine—Decreased appetite—Doxorubicin—hematologic cancer	1.85e-05	0.000115	CcSEcCtD
Desipramine—Headache—Prednisone—hematologic cancer	1.84e-05	0.000114	CcSEcCtD
Desipramine—Fatigue—Doxorubicin—hematologic cancer	1.83e-05	0.000114	CcSEcCtD
Desipramine—Urticaria—Epirubicin—hematologic cancer	1.83e-05	0.000113	CcSEcCtD
Desipramine—Constipation—Doxorubicin—hematologic cancer	1.82e-05	0.000113	CcSEcCtD
Desipramine—Abdominal pain—Epirubicin—hematologic cancer	1.82e-05	0.000113	CcSEcCtD
Desipramine—Body temperature increased—Epirubicin—hematologic cancer	1.82e-05	0.000113	CcSEcCtD
Desipramine—Asthenia—Methotrexate—hematologic cancer	1.76e-05	0.000109	CcSEcCtD
Desipramine—Feeling abnormal—Doxorubicin—hematologic cancer	1.75e-05	0.000109	CcSEcCtD
Desipramine—Nausea—Prednisone—hematologic cancer	1.75e-05	0.000108	CcSEcCtD
Desipramine—Pruritus—Methotrexate—hematologic cancer	1.74e-05	0.000108	CcSEcCtD
Desipramine—Urticaria—Doxorubicin—hematologic cancer	1.69e-05	0.000105	CcSEcCtD
Desipramine—Abdominal pain—Doxorubicin—hematologic cancer	1.68e-05	0.000104	CcSEcCtD
Desipramine—Body temperature increased—Doxorubicin—hematologic cancer	1.68e-05	0.000104	CcSEcCtD
Desipramine—Diarrhoea—Methotrexate—hematologic cancer	1.68e-05	0.000104	CcSEcCtD
Desipramine—Asthenia—Epirubicin—hematologic cancer	1.65e-05	0.000102	CcSEcCtD
Desipramine—Pruritus—Epirubicin—hematologic cancer	1.63e-05	0.000101	CcSEcCtD
Desipramine—Dizziness—Methotrexate—hematologic cancer	1.62e-05	0.000101	CcSEcCtD
Desipramine—Diarrhoea—Epirubicin—hematologic cancer	1.57e-05	9.75e-05	CcSEcCtD
Desipramine—Vomiting—Methotrexate—hematologic cancer	1.56e-05	9.69e-05	CcSEcCtD
Desipramine—Rash—Methotrexate—hematologic cancer	1.55e-05	9.61e-05	CcSEcCtD
Desipramine—Dermatitis—Methotrexate—hematologic cancer	1.55e-05	9.6e-05	CcSEcCtD
Desipramine—Headache—Methotrexate—hematologic cancer	1.54e-05	9.54e-05	CcSEcCtD
Desipramine—Asthenia—Doxorubicin—hematologic cancer	1.53e-05	9.46e-05	CcSEcCtD
Desipramine—Dizziness—Epirubicin—hematologic cancer	1.52e-05	9.43e-05	CcSEcCtD
Desipramine—Pruritus—Doxorubicin—hematologic cancer	1.51e-05	9.33e-05	CcSEcCtD
Desipramine—Vomiting—Epirubicin—hematologic cancer	1.46e-05	9.07e-05	CcSEcCtD
Desipramine—Nausea—Methotrexate—hematologic cancer	1.46e-05	9.05e-05	CcSEcCtD
Desipramine—Diarrhoea—Doxorubicin—hematologic cancer	1.46e-05	9.03e-05	CcSEcCtD
Desipramine—Rash—Epirubicin—hematologic cancer	1.45e-05	8.99e-05	CcSEcCtD
Desipramine—Dermatitis—Epirubicin—hematologic cancer	1.45e-05	8.98e-05	CcSEcCtD
Desipramine—Headache—Epirubicin—hematologic cancer	1.44e-05	8.93e-05	CcSEcCtD
Desipramine—Dizziness—Doxorubicin—hematologic cancer	1.41e-05	8.72e-05	CcSEcCtD
Desipramine—Nausea—Epirubicin—hematologic cancer	1.37e-05	8.47e-05	CcSEcCtD
Desipramine—Vomiting—Doxorubicin—hematologic cancer	1.35e-05	8.39e-05	CcSEcCtD
Desipramine—Rash—Doxorubicin—hematologic cancer	1.34e-05	8.32e-05	CcSEcCtD
Desipramine—Dermatitis—Doxorubicin—hematologic cancer	1.34e-05	8.31e-05	CcSEcCtD
Desipramine—Headache—Doxorubicin—hematologic cancer	1.33e-05	8.26e-05	CcSEcCtD
Desipramine—Nausea—Doxorubicin—hematologic cancer	1.26e-05	7.84e-05	CcSEcCtD
Desipramine—ADRB2—Signaling Pathways—NRAS—hematologic cancer	1.02e-06	1.09e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CASP3—hematologic cancer	1.02e-06	1.08e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—IL6—hematologic cancer	1.02e-06	1.08e-05	CbGpPWpGaD
Desipramine—CHRM2—GPCR downstream signaling—AKT1—hematologic cancer	1.02e-06	1.08e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—IL2—hematologic cancer	1.02e-06	1.08e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—CREBBP—hematologic cancer	1.01e-06	1.08e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CCND1—hematologic cancer	1.01e-06	1.08e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—IL6—hematologic cancer	1.01e-06	1.08e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—JUN—hematologic cancer	1.01e-06	1.08e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—IL6—hematologic cancer	1.01e-06	1.08e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—VEGFA—hematologic cancer	1.01e-06	1.07e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CASP3—hematologic cancer	1.01e-06	1.07e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IL2—hematologic cancer	1.01e-06	1.07e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—PIK3CA—hematologic cancer	1e-06	1.07e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—VEGFA—hematologic cancer	1e-06	1.07e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—IL6—hematologic cancer	1e-06	1.07e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CCND1—hematologic cancer	9.98e-07	1.07e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—STAT3—hematologic cancer	9.97e-07	1.06e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—MAPK3—hematologic cancer	9.96e-07	1.06e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—JUN—hematologic cancer	9.96e-07	1.06e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CCND1—hematologic cancer	9.96e-07	1.06e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—NRAS—hematologic cancer	9.95e-07	1.06e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—JUN—hematologic cancer	9.94e-07	1.06e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CCND1—hematologic cancer	9.93e-07	1.06e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—STAT3—hematologic cancer	9.92e-07	1.06e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—JUN—hematologic cancer	9.91e-07	1.06e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—NRAS—hematologic cancer	9.9e-07	1.06e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CCND1—hematologic cancer	9.89e-07	1.06e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—GSTP1—hematologic cancer	9.88e-07	1.05e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—JUN—hematologic cancer	9.87e-07	1.05e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PIK3CD—hematologic cancer	9.86e-07	1.05e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—PTEN—hematologic cancer	9.83e-07	1.05e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CDKN1A—hematologic cancer	9.81e-07	1.05e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CCND1—hematologic cancer	9.8e-07	1.05e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—PTEN—hematologic cancer	9.79e-07	1.04e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—JUN—hematologic cancer	9.78e-07	1.04e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—MAPK3—hematologic cancer	9.74e-07	1.04e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—ALB—hematologic cancer	9.73e-07	1.04e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—TP53—hematologic cancer	9.7e-07	1.04e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—MYC—hematologic cancer	9.69e-07	1.03e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TGFB1—hematologic cancer	9.66e-07	1.03e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CDKN1A—hematologic cancer	9.65e-07	1.03e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CDKN1A—hematologic cancer	9.63e-07	1.03e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—PTEN—hematologic cancer	9.63e-07	1.03e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—PTEN—hematologic cancer	9.62e-07	1.03e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PIK3CD—hematologic cancer	9.62e-07	1.03e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—PTEN—hematologic cancer	9.61e-07	1.03e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CDKN1A—hematologic cancer	9.6e-07	1.02e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—PIK3CA—hematologic cancer	9.6e-07	1.02e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—PTEN—hematologic cancer	9.58e-07	1.02e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MAPK8—hematologic cancer	9.58e-07	1.02e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CDKN1A—hematologic cancer	9.57e-07	1.02e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—CREBBP—hematologic cancer	9.56e-07	1.02e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—AKT1—hematologic cancer	9.55e-07	1.02e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—PTEN—hematologic cancer	9.55e-07	1.02e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—MAPK3—hematologic cancer	9.53e-07	1.02e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—ALB—hematologic cancer	9.5e-07	1.01e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CDKN1A—hematologic cancer	9.48e-07	1.01e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—MAPK3—hematologic cancer	9.48e-07	1.01e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—MYC—hematologic cancer	9.48e-07	1.01e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—PTEN—hematologic cancer	9.46e-07	1.01e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TGFB1—hematologic cancer	9.45e-07	1.01e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MAPK8—hematologic cancer	9.42e-07	1.01e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MAPK8—hematologic cancer	9.4e-07	1e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—AKT1—hematologic cancer	9.4e-07	1e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—AKT1—hematologic cancer	9.38e-07	1e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MAPK8—hematologic cancer	9.37e-07	1e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—EP300—hematologic cancer	9.37e-07	1e-05	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—PIK3CA—hematologic cancer	9.36e-07	9.99e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—ABCB1—hematologic cancer	9.35e-07	9.98e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—AKT1—hematologic cancer	9.35e-07	9.98e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MAPK8—hematologic cancer	9.34e-07	9.97e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—EP300—hematologic cancer	9.34e-07	9.96e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—AKT1—hematologic cancer	9.32e-07	9.94e-06	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PIK3R1—hematologic cancer	9.31e-07	9.94e-06	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—TP53—hematologic cancer	9.29e-07	9.91e-06	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—HRAS—hematologic cancer	9.27e-07	9.9e-06	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—MYC—hematologic cancer	9.27e-07	9.89e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MAPK8—hematologic cancer	9.25e-07	9.87e-06	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TGFB1—hematologic cancer	9.24e-07	9.87e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—AKT1—hematologic cancer	9.23e-07	9.85e-06	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—MYC—hematologic cancer	9.22e-07	9.84e-06	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TGFB1—hematologic cancer	9.2e-07	9.81e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—EP300—hematologic cancer	9.19e-07	9.8e-06	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—EP300—hematologic cancer	9.18e-07	9.8e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—EP300—hematologic cancer	9.17e-07	9.78e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	9.16e-07	9.78e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—EP300—hematologic cancer	9.14e-07	9.75e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—EP300—hematologic cancer	9.11e-07	9.72e-06	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PIK3R1—hematologic cancer	9.09e-07	9.7e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—NCOR1—hematologic cancer	9.08e-07	9.69e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—GSTM1—hematologic cancer	9.08e-07	9.69e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—SRC—hematologic cancer	9.08e-07	9.69e-06	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	9.07e-07	9.68e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—EP300—hematologic cancer	9.02e-07	9.63e-06	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—KRAS—hematologic cancer	8.95e-07	9.55e-06	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—ALB—hematologic cancer	8.95e-07	9.55e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—SRC—hematologic cancer	8.93e-07	9.53e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—SRC—hematologic cancer	8.91e-07	9.51e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—SRC—hematologic cancer	8.88e-07	9.48e-06	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—HRAS—hematologic cancer	8.88e-07	9.48e-06	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—IL6—hematologic cancer	8.88e-07	9.47e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—SRC—hematologic cancer	8.86e-07	9.45e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—VEGFA—hematologic cancer	8.84e-07	9.44e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—SRC—hematologic cancer	8.77e-07	9.36e-06	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—KRAS—hematologic cancer	8.76e-07	9.35e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—STAT3—hematologic cancer	8.76e-07	9.34e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	8.74e-07	9.33e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—NRAS—hematologic cancer	8.73e-07	9.32e-06	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—PIK3CA—hematologic cancer	8.72e-07	9.31e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—VEGFA—hematologic cancer	8.7e-07	9.29e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—VEGFA—hematologic cancer	8.68e-07	9.27e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—VEGFA—hematologic cancer	8.65e-07	9.24e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—VEGFA—hematologic cancer	8.63e-07	9.21e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—STAT3—hematologic cancer	8.61e-07	9.19e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—STAT3—hematologic cancer	8.6e-07	9.17e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—NRAS—hematologic cancer	8.59e-07	9.17e-06	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PIK3CB—hematologic cancer	8.59e-07	9.17e-06	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—PIK3CA—hematologic cancer	8.59e-07	9.17e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—NRAS—hematologic cancer	8.58e-07	9.15e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—STAT3—hematologic cancer	8.57e-07	9.15e-06	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	8.56e-07	9.14e-06	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—KRAS—hematologic cancer	8.56e-07	9.14e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—NRAS—hematologic cancer	8.55e-07	9.12e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—VEGFA—hematologic cancer	8.54e-07	9.12e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—STAT3—hematologic cancer	8.54e-07	9.12e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—NRAS—hematologic cancer	8.52e-07	9.09e-06	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—KRAS—hematologic cancer	8.52e-07	9.09e-06	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—IL6—hematologic cancer	8.5e-07	9.07e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—STAT3—hematologic cancer	8.46e-07	9.03e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—NRAS—hematologic cancer	8.44e-07	9.01e-06	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PIK3CB—hematologic cancer	8.39e-07	8.95e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MAPK3—hematologic cancer	8.36e-07	8.93e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MAPK3—hematologic cancer	8.23e-07	8.78e-06	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—PIK3CA—hematologic cancer	8.22e-07	8.78e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MAPK3—hematologic cancer	8.21e-07	8.77e-06	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—AKT1—hematologic cancer	8.19e-07	8.74e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MAPK3—hematologic cancer	8.19e-07	8.74e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MAPK3—hematologic cancer	8.16e-07	8.71e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MYC—hematologic cancer	8.14e-07	8.68e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TGFB1—hematologic cancer	8.12e-07	8.66e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—CREBBP—hematologic cancer	8.1e-07	8.65e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MAPK3—hematologic cancer	8.08e-07	8.62e-06	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—PIK3CA—hematologic cancer	8.06e-07	8.6e-06	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—PIK3CA—hematologic cancer	8.04e-07	8.59e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—MTHFR—hematologic cancer	8.03e-07	8.57e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MYC—hematologic cancer	8e-07	8.54e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MYC—hematologic cancer	7.99e-07	8.53e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TGFB1—hematologic cancer	7.99e-07	8.52e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TGFB1—hematologic cancer	7.97e-07	8.5e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MYC—hematologic cancer	7.96e-07	8.5e-06	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TP53—hematologic cancer	7.96e-07	8.49e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TGFB1—hematologic cancer	7.94e-07	8.48e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MYC—hematologic cancer	7.94e-07	8.47e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TGFB1—hematologic cancer	7.92e-07	8.45e-06	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	7.9e-07	8.44e-06	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—PIK3CA—hematologic cancer	7.87e-07	8.4e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MYC—hematologic cancer	7.86e-07	8.39e-06	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—AKT1—hematologic cancer	7.84e-07	8.37e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TGFB1—hematologic cancer	7.84e-07	8.37e-06	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—PIK3CA—hematologic cancer	7.83e-07	8.35e-06	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TP53—hematologic cancer	7.78e-07	8.31e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	7.68e-07	8.2e-06	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—AKT1—hematologic cancer	7.65e-07	8.16e-06	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TP53—hematologic cancer	7.61e-07	8.12e-06	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—HRAS—hematologic cancer	7.61e-07	8.12e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—ALB—hematologic cancer	7.58e-07	8.09e-06	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TP53—hematologic cancer	7.57e-07	8.08e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—KRAS—hematologic cancer	7.52e-07	8.02e-06	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—HRAS—hematologic cancer	7.44e-07	7.94e-06	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PTEN—hematologic cancer	7.42e-07	7.92e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—KRAS—hematologic cancer	7.4e-07	7.89e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—KRAS—hematologic cancer	7.38e-07	7.88e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—KRAS—hematologic cancer	7.36e-07	7.85e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—KRAS—hematologic cancer	7.33e-07	7.83e-06	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—IL6—hematologic cancer	7.28e-07	7.77e-06	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—HRAS—hematologic cancer	7.28e-07	7.77e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—KRAS—hematologic cancer	7.26e-07	7.75e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	7.25e-07	7.74e-06	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PTEN—hematologic cancer	7.25e-07	7.74e-06	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—HRAS—hematologic cancer	7.24e-07	7.73e-06	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—AKT1—hematologic cancer	7.13e-07	7.61e-06	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—IL6—hematologic cancer	7.12e-07	7.6e-06	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—EP300—hematologic cancer	7.08e-07	7.56e-06	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—AKT1—hematologic cancer	7.02e-07	7.49e-06	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—IL6—hematologic cancer	6.97e-07	7.43e-06	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—PIK3CA—hematologic cancer	6.93e-07	7.4e-06	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—IL6—hematologic cancer	6.93e-07	7.4e-06	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—EP300—hematologic cancer	6.91e-07	7.38e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—PIK3CA—hematologic cancer	6.91e-07	7.37e-06	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PTEN—hematologic cancer	6.83e-07	7.29e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—PIK3CA—hematologic cancer	6.8e-07	7.25e-06	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—PIK3CA—hematologic cancer	6.79e-07	7.25e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—PIK3CA—hematologic cancer	6.78e-07	7.24e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—PIK3CA—hematologic cancer	6.76e-07	7.21e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	6.74e-07	7.2e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—PIK3CA—hematologic cancer	6.74e-07	7.19e-06	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—AKT1—hematologic cancer	6.72e-07	7.17e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	6.7e-07	7.15e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TP53—hematologic cancer	6.68e-07	7.13e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—PIK3CA—hematologic cancer	6.67e-07	7.12e-06	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—AKT1—hematologic cancer	6.58e-07	7.03e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TP53—hematologic cancer	6.57e-07	7.02e-06	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—AKT1—hematologic cancer	6.57e-07	7.01e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TP53—hematologic cancer	6.56e-07	7e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TP53—hematologic cancer	6.54e-07	6.98e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TP53—hematologic cancer	6.52e-07	6.96e-06	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—EP300—hematologic cancer	6.51e-07	6.95e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TP53—hematologic cancer	6.45e-07	6.89e-06	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—AKT1—hematologic cancer	6.43e-07	6.86e-06	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—AKT1—hematologic cancer	6.39e-07	6.82e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—HRAS—hematologic cancer	6.39e-07	6.82e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—HRAS—hematologic cancer	6.29e-07	6.71e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—HRAS—hematologic cancer	6.27e-07	6.7e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—HRAS—hematologic cancer	6.25e-07	6.67e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CREBBP—hematologic cancer	6.25e-07	6.67e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—HRAS—hematologic cancer	6.23e-07	6.65e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—HRAS—hematologic cancer	6.17e-07	6.59e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—IL6—hematologic cancer	6.12e-07	6.53e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—IL6—hematologic cancer	6.02e-07	6.42e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—IL6—hematologic cancer	6e-07	6.41e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—IL6—hematologic cancer	5.99e-07	6.39e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—IL6—hematologic cancer	5.97e-07	6.37e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	5.93e-07	6.33e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IL6—hematologic cancer	5.91e-07	6.31e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—ALB—hematologic cancer	5.85e-07	6.25e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PTEN—hematologic cancer	5.79e-07	6.17e-06	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—AKT1—hematologic cancer	5.66e-07	6.04e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—AKT1—hematologic cancer	5.64e-07	6.02e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	5.6e-07	5.97e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—AKT1—hematologic cancer	5.55e-07	5.92e-06	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—AKT1—hematologic cancer	5.55e-07	5.92e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—AKT1—hematologic cancer	5.54e-07	5.91e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—AKT1—hematologic cancer	5.52e-07	5.89e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—EP300—hematologic cancer	5.52e-07	5.89e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—AKT1—hematologic cancer	5.5e-07	5.87e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—AKT1—hematologic cancer	5.45e-07	5.82e-06	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PIK3CA—hematologic cancer	5.24e-07	5.59e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	5.17e-07	5.51e-06	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PIK3CA—hematologic cancer	5.11e-07	5.46e-06	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	4.82e-07	5.14e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PTEN—hematologic cancer	4.46e-07	4.77e-06	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—AKT1—hematologic cancer	4.28e-07	4.57e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—EP300—hematologic cancer	4.26e-07	4.54e-06	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—AKT1—hematologic cancer	4.18e-07	4.46e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	4.08e-07	4.36e-06	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—AKT1—hematologic cancer	3.94e-07	4.2e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—AKT1—hematologic cancer	3.33e-07	3.56e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	3.15e-07	3.36e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—AKT1—hematologic cancer	2.57e-07	2.75e-06	CbGpPWpGaD
